NOTES TO EDITORS
This study was conducted by researchers from the University of Melbourne, Australia; Harvard Medical School, USA; Sangath, India; Universidade Federal do Rio Grande do Sul, Brazil; Deakin University, Australia; VU University Amsterdam, The Netherlands; Kyoto University Graduate School of Medicine/School of Public Health, Japan; Harvard Medical School, USA; University of Campania L. Vanvitelli, Italy; University of Pittsburgh School of Medicine, USA; Columbia University Vagelos College of Physicians and Surgeons, USA: University of Zimbabwe, Zimbabwe; Kings College London, UK; Columbia University, USA; London School of Economics and Political Science, UK; George Washington University, USA; Icahn School of Medicine at Mount Sinai, USA; Vrije Universiteit, The Netherlands; Central South University Xiangya School of Public Health, China; The University of Texas Southwestern Medical Center, USA; Dalhousie University, Canada; Sneha, Suicide Prevention Centre and Voluntary Health Services, India; and The Wellcome Trust, UK.
If you are reporting on this study, please consider including a link to information and support for your readers. In the USA, the National Suicide Prevention Lifeline can be contacted on 1-800-273-TALK (8255) or visit https://suicidepreventionlifeline.org/. In the UK, the number is 116 123, or email: jo@samaritans.org or visit www.samaritans.org For those outside the USA and UK, Befrienders Worldwide also provide support: http://www.befrienders.org/
[1] https://www.who.int/news-room/fact-sheets/detail/depression
[2] Quotes direct from authors and cannot be found in text of Commission.
[3] Mental Health and Substance Use: https://www.who.int/teams/mental-health-and-substance-use/promotion-prevention/mental-health-in-the-workplace